← Browse by Condition
Medical Condition

neovascular age related macular degeneration nvamd

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07205887 Phase 2
Recruiting

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

Enrollment
160 pts
Location
United States
Sponsor
EyeBiotech Ltd.
View Trial →